Navigation Links
Consuming polyunsaturated fatty acids may lower the incidence of gum disease
Date:10/25/2010

St. Louis, MO, October 26, 2010 Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and tooth loss. Although traditional treatments concentrate on the bacterial infection, more recent strategies target the inflammatory response. In an article in the November issue of the Journal of the American Dietetic Association, researchers from Harvard Medical School and Harvard School of Public Health found that dietary intake of polyunsaturated fatty acids (PUFAs) like fish oil, known to have anti-inflammatory properties, shows promise for the effective treatment and prevention of periodontitis.

"We found that n-3 fatty acid intake, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are inversely associated with periodontitis in the US population," commented Asghar Z. Naqvi, MPH, MNS, Department of Medicine, Beth Israel Deaconess Medical Center. "To date, the treatment of periodontitis has primarily involved mechanical cleaning and local antibiotic application. Thus, a dietary therapy, if effective, might be a less expensive and safer method for the prevention and treatment of periodontitis. Given the evidence indicating a role for n-3 fatty acids in other chronic inflammatory conditions, it is possible that treating periodontitis with n-3 fatty acids could have the added benefit of preventing other chronic diseases associated with inflammation, including stoke as well."

Using data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey with a complex multistage, stratified probability sample, investigators found that dietary intake of the PUFAs DHA and (EPA) were associated with a decreased prevalence of periodontitis, although linolenic acid (LNA) did not show this association.

The study involved over 9,000 adults who participated in NHANES between 1999 and 2004 who had received dental examinations. Dietary DHA, EPA and LNA intake were estimated from 24-hour food recall interviews and data regarding supplementary use of PUFAs were captured as well. The NHANES study also collected extensive demographic, ethnic, educational and socioeconomic data, allowing the researchers to take other factors into consideration that might obscure the results.

The prevalence of periodontitis in the study sample was 8.2%. There was an approximately 20% reduction in periodontitis prevalence in those subjects who consumed the highest amount of dietary DHA. The reduction correlated with EPA was smaller, while the correlation to LNA was not statistically significant.

In an accompanying commentary, Elizabeth Krall Kaye, PhD, Professor, Boston University Henry M. Goldman School of Dental Medicine, notes that three interesting results emerged from this study. One was that significantly reduced odds of periodontal disease were observed at relatively modest intakes of DHA and EPA. Another result of note was the suggestion of a threshold dose; that is, there seemed to be no further reduction in odds or periodontal disease conferred by intakes at the highest levels. Third, the results were no different when dietary plus supplemental intakes were examined. These findings are encouraging in that they suggest it may be possible to attain clinically meaningful benefits for periodontal disease at modest levels of n-3 fatty acid intakes from foods.

Foods that contain significant amounts of polyunsaturated fats include fatty fish like salmon, peanut butter, margarine, and nuts.


'/>"/>

Contact: Nancy Burns
jadamedia@elsevier.com
314-447-8013
Elsevier Health Sciences
Source:Eurekalert

Related biology news :

1. Pregnant women consuming flaxseed oil have high risk of premature birth
2. Young men consuming an alarming amount of salt
3. Unknowlingly consuming endangered tuna
4. Consuming vegetables linked to decreased breast cancer risk in African-American women
5. Fattysaurus or thinnysaurus? How dinosaurs measure up with laser imaging
6. Eating fatty fish once a week reduces mens risk of heart failure
7. Omega fatty acid balance can alter immunity and gene expression
8. Fatty foods -- not empty stomach -- fire up hunger hormone
9. Omega-3 fatty acids appear to impact AMD progression
10. How much omega-3 fatty acid do we need to prevent cardiovascular disease?
11. U of I study: Lack of omega-6 fatty acid linked to severe dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/20/2016)... N.C. and GENEVA, Dec, 20, 2016 /PRNewswire/ ... biometric data sensor technology, and STMicroelectronics ... the spectrum of electronics applications, announced today the ... development kit for biometric wearables that includes ST,s ... with Valencell,s Benchmark™ biometric sensor system. ...
(Date:12/15/2016)... , December 15, 2016 Arvato ... an agreement with NuData Security, an award-winning international ... will enable clients to focus on good customer experience, balancing ... regulation. ... In order to provide a one-stop fraud prevention suite, Arvato ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... ... January 24, 2017 , ... Nanomedical Diagnostics ... for fragment-based screening, will showcase its proprietary Field Effect Biosensing (FEB) ... Screening (SLAS) conference in Washington, D.C. from Feb. 6 to Feb. 8. , ...
(Date:1/24/2017)... ... January 23, 2017 , ... Edward ... first-ever recipient of the National Academy of Sciences Prize in Food and Agriculture ... nutrition. , The annual National Academy of Sciences (NAS) Prize in Food and ...
(Date:1/24/2017)... , Jan. 23, 2017  Today, the Fisher Center ... have funded an important study that could lead to ... onset of Alzheimer,s disease. This groundbreaking research was conducted ... led by Nobel Laureate Dr. Paul Greengard , ... disease. Fisher Center scientists have linked a ...
(Date:1/23/2017)... - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) ... Zealand based Phase 1 trial with severe ... in reducing inflamed protein biomarkers in patients with severe ... that this is the first time in medical history ... made between epigenetic regulation and its potential for positive ...
Breaking Biology Technology: